Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Clinical trial NCT00639717 · COMPLETED
Trial details
- NCT number
- NCT00639717
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-01-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.